重型急性脑损伤临床试验不良事件登记:德尔菲共识研究
该研究通过结构化德尔菲流程,由10名北欧神经重症专家对重型急性脑损伤临床试验不良事件登记表进行两轮反馈修订,最终形成包含28项不良事件的标准化登记工具,其中27项达成定义共识(≥70%同意),旨在提升临床试验危害报告的透明度、准确性和一致性。
要点
- 德尔菲专家组由10名北欧重症、神经外科或神经内科专家组成。
- 最终登记工具涵盖28项不良事件,27项达成≥70%共识。
- 谵妄未达共识但经修订后保留在登记工具中。
核心结论
- 由10名北欧神经重症专家通过德尔菲流程审阅并修订了重型急性脑损伤临床试验不良事件登记工具。
- 该工具旨在提升临床试验危害报告的透明度、准确性和一致性。
研究设计与样本
- 采用结构化德尔菲流程,包含两轮来自北欧国家临床专家的反馈。
- 第一轮问卷包含初步登记表,列出25项重症监护和重型急性脑损伤相关不良事件定义建议。
- 根据第一轮反馈修订工具后,在第二轮以问卷形式发送修订版登记表。
- 德尔菲专家组由10名具有重症监护、神经外科或神经内科经验的专科医生组成。
主要发现
- 对最终28项不良事件中的27项达成不良事件定义共识(定义为≥70%同意)。
- 谵妄在第二轮德尔菲中未达到共识水平,但经修订后保留在登记工具中。
- 最终版登记工具包含28项适用于重型急性脑损伤患者的不良事件。
关键数值与推荐
- 共识定义:不良事件定义达成共识的标准为≥70%同意。
- 最终登记工具包含28项不良事件。
- 27项不良事件达成共识,1项(谵妄)未达共识但经修订后保留。
临床怎么用
- 该工具可用于重型急性脑损伤临床试验中标准化记录不良事件和反应。
- 通过标准化记录,有望提升临床试验危害报告的透明度、准确性和一致性。
局限性
- 德尔菲专家组仅由10名北欧专家组成,地域和人数有限。
- 谵妄一项未在第二轮达到共识水平。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Understanding the adverse effects of an intervention is important for evaluating its overall effect. Clinical trials mainly focus on the benefits of interventions with a risk of overlooking potential harms. Additionally, patients with severe acute brain injury frequently experience adverse events from other causes, which complicates the recording of harms in trials involving such participants. In this study, we developed a standardized registration form for recording adverse events in trial participants with severe acute brain injury using a structured Delphi process. METHODS: After developing the tool, we employed a Delphi process comprising two rounds of feedback from clinical experts in Nordic countries. In the first round, the Delphi panel received a questionnaire with a preliminary registration form, consisting of a list of 25 suggested definitions for adverse events relevant in the context of intensive care and severe acute brain injury. Based on feedback from the Delphi panel, we revised the tool and sent the revised registration form as a questionnaire in the second Delphi round. RESULTS: The Delphi panel consisted of 10 specialist physicians with experience in intensive care, neurosurgery or neurology. Consensus on the definition of an adverse event (defined as ≥ 70% agreement) was achieved for 27 out of the resulting 28 adverse events; for one adverse event, delirium, the level of agreement did not reach consensus in the second Delphi round; however, following revision, it was retained in the registration tool. The final version of the registration tool consisted of 28 adverse events for patients with severe acute brain injury. CONCLUSION: A new tool for registration of adverse events and reactions in trial participants with severe acute brain injury was reviewed and refined by a Delphi panel of 10 Nordic neurocritical-care experts. The intention is to enhance the transparency, accuracy and consistency of reporting harms in clinical trials. Through thorough and standardized recording, the tool has the potential to improve the overall quality of clinical trials.
引用
- Andreasen TH, Riberholt CG, Fenger AW, et al. Adverse events registration in clinical trial participants with severe acute brain injury: a Delphi consensus study. Acta Neurochir (Wien). 2025. PMID: 41428104. doi:10.1007/s00701-025-06724-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。